{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:13:59Z","timestamp":1794410039740,"version":"4.9.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Friedreich ataxia (FRDA) is a recessive neurodegenerative disease characterized by progressive ataxia, dyscoordination, and loss of vision. The variable length of the pathogenic GAA triplet repeat expansion in the <jats:italic>FXN<\/jats:italic> gene in part explains the interindividual variability in the severity of disease. The GAA repeat expansion leads to epigenetic silencing of <jats:italic>FXN;<\/jats:italic> therefore, variability in properties of epigenetic effector proteins could also regulate the severity of FRDA.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In an exploratory analysis, DNA from 88 individuals with FRDA was analyzed to determine if any of five non-synonymous SNPs in <jats:italic>HDAC<\/jats:italic>s\/<jats:italic>SIRT<\/jats:italic>s predicted FRDA disease severity. Results suggested the need for a full analysis at the rs352493 locus in <jats:italic>SIRT6<\/jats:italic> (<jats:italic>p<\/jats:italic>.Asn46Ser). In a cohort of 569 subjects with FRDA, disease features were compared between subjects homozygous for the common thymine <jats:italic>SIRT6<\/jats:italic> variant (TT) and those with the less common cytosine variant on one allele and thymine on the other (CT). The biochemical properties of both variants of SIRT6 were analyzed and compared.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Linear regression in the exploratory cohort suggested that an SNP (rs352493) in <jats:italic>SIRT6<\/jats:italic> correlated with neurological severity in FRDA. The follow-up analysis in a larger cohort agreed with the initial result that the genotype of <jats:italic>SIRT6<\/jats:italic> at the locus rs352493 predicted the severity of disease features of FRDA. Those in the CT <jats:italic>SIRT6<\/jats:italic> group performed better on measures of neurological and visual function over time than those in the more common TT <jats:italic>SIRT6<\/jats:italic> group. The Asn to Ser amino acid change resulting from the SNP in <jats:italic>SIRT6<\/jats:italic> did not alter the expression or enzymatic activity of SIRT6 or frataxin, but iPSC-derived neurons from people with FRDA in the CT <jats:italic>SIRT6<\/jats:italic> group showed whole transcriptome differences compared to those in the TT <jats:italic>SIRT6<\/jats:italic> group.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> People with FRDA in the CT <jats:italic>SIRT6<\/jats:italic> group have less severe neurological and visual dysfunction than those in the TT <jats:italic>SIRT6<\/jats:italic> group. Biochemical analyses indicate that the benefit conferred by T to C SNP in <jats:italic>SIRT6<\/jats:italic> does not come from altered expression or enzymatic activity of SIRT6 or frataxin but is associated with changes in the transcriptome.<\/jats:p>","DOI":"10.3389\/fmolb.2022.933788","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T05:12:43Z","timestamp":1662354763000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["A non-synonymous single nucleotide polymorphism in SIRT6 predicts neurological severity in Friedreich ataxia"],"prefix":"10.3389","volume":"9","author":[{"given":"Layne N.","family":"Rodden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rummey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Na","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lagedrost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Regner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Brocht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalaf","family":"Bushara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Delatycki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Ravina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"Subramony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Wilmot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Zesiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bolotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Domissy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Soragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gottesfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/adc.59.3.217","article-title":"Friedreich's ataxia. A clinical review with neurophysiological and echocardiographic findings","volume":"59","author":"Ackroyd","year":"1984","journal-title":"Arch. Dis. Child."},{"key":"B2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1017\/s0317167100025476","article-title":"Genetic and family studies in Friedreich's ataxia","volume":"3","author":"Andermann","year":"1976","journal-title":"Can. J. Neurol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s10072-006-0617-8","article-title":"Friedreich's ataxia: clinical heterogeneity in two sisters","volume":"27","author":"Armani","year":"2006","journal-title":"Neurol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.276.5319.1709","article-title":"Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin","volume":"276","author":"Babcock","year":"1997","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/jnen\/nlx047","article-title":"Heart and nervous system pathology in compound heterozygous Friedreich ataxia","volume":"76","author":"Becker","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B6","first-page":"1251","article-title":"Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion","volume":"60","author":"Bidichandani","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"41469","DOI":"10.1074\/jbc.M006539200","article-title":"Two-step processing of human frataxin by mitochondrial processing peptidase. Precursor and intermediate forms are cleaved at different rates","volume":"275","author":"Cavadini","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets","volume":"4","author":"Chang","year":"2015","journal-title":"GigaScience"},{"key":"B10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/1531-8249(199902)45:2<200:aid-ana10>3.0.co;2-u","article-title":"Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes","volume":"45","author":"Coss\u00e9e","year":"1999","journal-title":"Ann. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e7914","DOI":"10.1371\/journal.pone.0007914","article-title":"Epigenetic silencing in Friedreich ataxia is associated with depletion of CTCF (CCCTC-binding factor) and antisense transcription","volume":"4","author":"De Biase","year":"2009","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/(sici)1096-8628(19991119)87:2<168::aid-ajmg8>3.0.co;2-2","article-title":"Clinical and genetic study of Friedreich ataxia in an Australian population","volume":"87","author":"Delatycki","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich's ataxia","volume":"335","author":"D\u00fcrr","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"B14","first-page":"554","article-title":"The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia","volume":"59","author":"Filla","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s100480050037","article-title":"The correlation of clinical phenotype in Friedreich ataxia with the site of point mutations in the FRDA gene","volume":"1","author":"Forrest","year":"1998","journal-title":"Neurogenetics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/mds.22912","article-title":"Measuring the rate of progression in Friedreich ataxia: Implications for clinical trial design","volume":"25","author":"Friedman","year":"2010","journal-title":"Mov. Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6798","DOI":"10.1021\/bi025566+","article-title":"Physical evidence that yeast frataxin is an iron storage protein","volume":"41","author":"Gakh","year":"2002","journal-title":"Biochemistry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1017\/s0317167100025464","article-title":"Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia","volume":"3","author":"Geoffroy","year":"1976","journal-title":"Can. J. Neurol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nchembio815","article-title":"Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia","volume":"2","author":"Herman","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/hmg\/7.9.1485","article-title":"Maturation of wild-type and mutated frataxin by the mitochondrial processing peptidase","volume":"7","author":"Koutnikova","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.stem.2010.09.014","article-title":"Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA-TTC triplet repeat instability","volume":"7","author":"Ku","year":"2010","journal-title":"Cell Stem Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2016.04.033","article-title":"SIRT6 suppresses pancreatic cancer through control of Lin28b","volume":"165","author":"Kugel","year":"2016","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1212\/wnl.54.12.2322","article-title":"Unique origin and specific ethnic distribution of the Friedreich ataxia GAA expansion","volume":"54","author":"Labuda","year":"2000","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1074\/jbc.RA118.006515","article-title":"Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures","volume":"294","author":"Lai","year":"2019","journal-title":"J. Biol. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/brain\/120.4.673","article-title":"Identification and sizing of the GAA trinucleotide repeat expansion of Friedreich's ataxia in 56 patients. Clinical and genetic correlates","volume":"120","author":"Lamont","year":"1997","journal-title":"Brain"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/01.wnl.0000218155.46739.90","article-title":"Measuring Friedreich ataxia: complementary features of examination and performance measures","volume":"66","author":"Lynch","year":"2006","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s004150050601","article-title":"Typical Friedreich's ataxia without GAA expansions and GAA expansion without typical Friedreich's ataxia","volume":"247","author":"McCabe","year":"2000","journal-title":"J. Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1093\/hmg\/ddy198","article-title":"Peripheral blood gene expression reveals an inflammatory transcriptomic signature in Friedreich's ataxia patients","volume":"27","author":"Nachun","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1242\/dmm.030536","article-title":"Comprehensive analysis of gene expression patterns in Friedreich's ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers","volume":"10","author":"Napierala","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"B30","doi-asserted-by":"publisher","first-page":"14575","DOI":"10.1074\/jbc.M111.218990","article-title":"Structure and biochemical functions of SIRT6","volume":"286","author":"Pan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/acn3.332","article-title":"Progression of Friedreich ataxia: Quantitative characterization over 5 years","volume":"3","author":"Patel","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1474-4422(14)70321-7","article-title":"Biological and clinical characteristics of the European friedreich's ataxia consortium for translational studies (EFACTS) cohort: a cross-sectional analysis of baseline data","volume":"14","author":"Reetz","year":"2015","journal-title":"Lancet. Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1093\/hmg\/ddaa267","article-title":"Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia","volume":"29","author":"Rodden","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"100213","DOI":"10.1016\/j.eclinm.2019.11.006","article-title":"Predictors of loss of ambulation in Friedreich's ataxia","volume":"18","author":"Rummey","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1093\/hmg\/ddn244","article-title":"The in vivo mitochondrial two-step maturation of human frataxin","volume":"17","author":"Schmucker","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.1093\/nar\/gkn604","article-title":"Long intronic GAA*TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia","volume":"36","author":"Soragni","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ana.24260","article-title":"Epigenetic therapy for Friedreich ataxia","volume":"76","author":"Soragni","year":"2014","journal-title":"Ann. Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1177\/0883073812448533","article-title":"Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia","volume":"27","author":"Soragni","year":"2012","journal-title":"J. Child. Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"Unit1.19","DOI":"10.1002\/0471142905.hg0119s68","article-title":"Quality control procedures for genome-wide association studies","volume":"1","author":"Turner","year":"2011","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"116642","DOI":"10.1016\/j.jns.2019.116642","article-title":"Health related quality of life in Friedreich Ataxia in a large heterogeneous cohort","volume":"410","author":"Xiong","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/sj.ejhg.5201257","article-title":"Extension of the mutation spectrum in friedreich's ataxia: detection of an exon deletion and novel missense mutations","volume":"12","author":"Z\u00fchlke","year":"2004","journal-title":"Eur. J. Hum. Genet."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.933788\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T05:12:46Z","timestamp":1662354766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.933788\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":41,"alternative-id":["10.3389\/fmolb.2022.933788"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.933788","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fmolb.2022.933788.s001","asserted-by":"subject"}]},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"article-number":"933788"}}